Although several studies have shown that patients with ovarian cancer fare better if they receive specialized care, many of these women are not being referred to a gynecologic oncologist. A recent chart review of over 1,000 patients with pelvic masses strongly suggests that when clinicians follow the expert referral guidelines issued by the Society of Gynecologic Oncologists and ACOG, patients are definitely the winners.
Although several studies have shown that patients with ovarian cancer fare better if they receive specialized care, many of these women are not being referred to a gynecologic oncologist. A recent chart review of over 1,000 patients with pelvic masses strongly suggests that when clinicians follow the expert referral guidelines issued by the Society of Gynecologic Oncologists and ACOG, patients are definitely the winners.
The SGO/ACOG guidelines for referring women with pelvic masses rely on 5 parameters: a patient's age, CA-125 levels, physical findings, imaging study results, and family history. When these signposts were used retrospectively to distinguish benign from malignant tumors, investigators found that universal application of the guidelines would have resulted in 70% of premenopausal women and 94% of postmenopausal women being referred to a specialist because they had ovarian cancer.
For women under age 50, SGO/ACOG recommend that ascites, evidence of abdominal or distant metastasis, family history of breast or ovarian cancer in a first-degree relative, and a CA-125 reading above 200 U/mL be used as the basis for referring to a specialist. In women 50 or older, the criteria are CA-125 above 35, ascites, a nodular or fixed pelvic mass, evidence of abdominal or distant metastasis, and the same family history.
Im SS, Gordon AN, Buttin BM, et al. Validation of referral guidelines for women with pelvic masses. Obstet Gynecol. 2005;105:35-41.
Variations found in testosterone therapy for women with HSDD
May 7th 2024Dive into the intricate landscape of testosterone therapy prescriptions among women with hypoactive sexual desire disorder, revealing diverse patterns in duration, administration routes, and estrogen co-administration.
Read More
Impact of weight, ferritin, and nutrition education on postpartum depression risk
May 7th 2024A recent study highlights the role of weight gain, ferritin levels, and nutritional education in influencing the risk of postpartum depression among pregnant women, urging for proactive measures during routine prenatal care.
Read More
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More